Early treated patients with PKU: Exploring the association between measures of metabolic control, cognitive performance and neurological health

Informazioni relative al progetto

TREPAPHEN

ID dell’accordo di sovvenzione: 329423

Progetto chiuso

Data di avvio 16 Settembre 2013

Data di completamento 15 Settembre 2015

Finanziato da

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Costo totale € 221 606,40

Contributo UE € 221 606,40

Coordinato da

ASTON UNIVERSITY
United Kingdom